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from a placenta cDNA library as a gene product that promoted
activation of matrix metalloproteinase (MMP)-2 mediated by mem-
brane type (MT) 1–MMP. Co-expression of GI24 with MT1-MMP in
HEK293T cells increased the cell-surface level of MT1-MMP con-
comitant with the cleavage of the GI24 at the juxtamembrane site
to shed the extracellular domain. HT1080 fibrosarcoma cells stably
transfected with the GI24 gene expressed a higher level of MT1-
MMP and showed more invasive ability in collagen gel than the
control cells. GI24 was cleaved in HT1080 cells, which was blocked
by the administration of MMP inhibitor BB94 or transfection of
small interfering RNA (siRNA) targeting MT1-MMP. GI24 expres-
sion is relatively high in some squamous carcinoma and hepatocar-
cinoma cell lines. Transfection of siRNA for GI24 into oral
squamous carcinoma-derived HSC-4 cells, which express GI24 and
MT1-MMP genes reduced the expression of not only GI24 but also
MT1-MMP, and attenuated invasive growth in the collagen matrix.
These results suggest that GI24 contributes to tumor-invasive
growth in the collagen matrix by augmenting cell surface MT1-
MMP. (Cancer Sci 2010; 101: 2368–2374)5To whom correspondence should be addressed.
E-mail: vhsato@kenroku.kanazawa-u.ac.jpC ells in tissues are surrounded by an extracellular matrix(ECM) that interacts with cells to regulate their activ-
ity.(1,2) Matrix metalloproteases (MMP) are a family of zinc-
dependent enzymes that degrade components of the ECM and
have been implicated in the pathological turnover of ECM in
tumor invasion and metastasis.(3–5) Contemporary research
divides the MMP family into two categories: (i) soluble-type
MMP, which are enzymes secreted in the extracellular milieu
that can diffuse and target cells in trans; and (ii) membrane-type
MMP (MT-MMP), another subset of MMP, display the common
structural domains of the MMP family, but present an additional
C-terminal extension that tethers them to the plasma mem-
branes, making them important effectors of pericellular ECM
degradation and proteolytic activities.(6) Membrane type 1
matrix metalloprotease (MT1-MMP) was the first MT-MMP to
be discovered as an activator of MMP-2 (gelatinase A),(7) but it
also cleaves multiple proteins in the pericellular milieu and
thereby regulates various cell functions, and has been shown to
promote cancer invasion and metastasis.(8) Many substrates of
MT1-MMP were identified, including ECM proteins (type I col-
lagen, fibronectin, vitronectin, laminin-1 and -5, and others), cell
adhesion molecules (CD44, syndecan-1, and av integrin), cyto-
kines (stromal cell-derived factor 1, transforming growth factor-
b, growth differentiation factor-1 (GDF-15), and others), and
latent forms of MMP-2 and MMP-13.(9–13) Processing of these
proteins by MT1-MMP alters their activities and thereby regu-
lates a variety of cellular functions, such as motility, invasion,
growth, differentiation and apoptosis. In addition, to cleaveCancer Sci | November 2010 | vol. 101 | no. 11 | 2368–2374different types of substrates, MT1-MMP associates with various
cellular molecules such as b1 integrins,(14) CD44(15) and tetra-
spanin proteins such as CD63,(16) CD151,(17) CD81 and oth-
ers,(18) which regulate MT1-MMP activity either positively or
negatively.(19,20) Subcellular localization and internaliza-
tion ⁄ recycling of MT1-MMP are considered important factors
for its activity at the cell surface.(21) Thus, expression cloning
strategy as a screening for molecules that regulate MT1-MMP
activity on the cell surface may provide a systemic method to
identify not only potential regulators but also substrates of
MT1-MMP.
Platelet receptor GI24 precursor, also named stress-induced
secreted protein 1 (SISP1) is a novel member of the immuno-
globulin superfamily; however, the function of GI24-encoding
protein remains unsolved thus far.(22) In this study, we demon-
strated for the first time that GI24 serves as not only as a posi-
tive regulator but also as a substrate of MT1-MMP, and
contributes at least in part to tumor invasion.
Materials and Methods
Materials. Dulbecco’s modified Eagle’s medium (DMEM)
was from Sigma (St Louis, MO, USA). Primers were synthe-
sized by Greiner Japan (Tokyo, Japan). A human placenta
cDNA library constructed in pEAK8 expression vector was
obtained from EdgeBio Systems (Gaithersburg, MD, USA).
Recombinant MT1-MMP catalytic domains tagged with FLAG
epitope at the COOH-terminus were prepared as described pre-
viously.(13) Monoclonal antibody against HA and GST were
purchased from Wako Pure Chemical Industries, Ltd (Osaka,
Japan) and Nacalai Tesque (Kyoto, Japan), respectively.
Monoclonal antibodies against FLAG epitope and tubulin were
purchased from Sigma. The monoclonal antibody against
MT1-MMP (222-3ER) was a gift from Daiichi Fine Chemical
Co. Ltd (Takaoka, Japan). Recombinant GI24 extracellular
domain protein was expressed in Escherichia (E.) coli, and the
polyclonal antibody against GI24 was prepared by injecting the
recombinant protein into rabbits.
Cell culture. Human embryonic kidney HEK293T, fibrosar-
coma HT1080, breast cancer MCF-7 and human oral squamous
cell carcinoma HSC-3 and HSC-4 cells were obtained from the
Health Science Research Bank (Osaka, Japan) and were cultured
in DMEM supplemented with 5% fetal calf serum. Hepatoma
Hep3B, PLC5 and Huh7, and cholangiocarcinoma Huh28 cells
were obtained from the Cell Resource Center for Biomedical
Research Institute of Development, Aging and Cancer of
Tohoku University, and cultured in DMEM supplemented with
10% fetal calf serum.doi: 10.1111/j.1349-7006.2010.01675.x
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Fig. 1. Expression cloning. In the first screening, plasmid DNA
aliquots from the human placenta cDNA library were co-transfected
with membrane type 1–matrix metalloproteinase (MT1-MMP) plasmid
into HEK293T cells cultured in 24-well microplates. At 48 h post-
transfection, cells were incubated with a MMP-2 sample for 1 h, and
cell lysates from each well were subjected to gelatin zymography.
Note that MMP-2 activation to generate the 62-kDa active form was
stimulated in lane 10, as indicated by an arrow (upper panel). In the
second screening, single clones of plasmid DNA were examined as
described above. Note that MMP-2 activation was enhanced in lanes
2, 4, 6 and 11, as indicated by arrowheads (lower panel).Plsamids. The expression plasmid for MT1-MMP or MT1-
MMP tagged with FLAG epitope (MT1-F) was described previ-
ously.(23) The expression plasmid for GI24 tagged with FLAG
or HA epitope at the COOH-terminus (GI24-F or GI24-HA,
respectively) was constructed as follows: a GI24 cDNA frag-
ment containing EcoRI restriction sites in place of the stop
codon was generated by PCR using GI24 cDNA in a pEAK8
plasmid as a template and PCR primers of pEAK8 forward pri-
mer (TTCATTCTCAAGCCTCAGACAGTGG) and flanking
reverse primer with an extra EcoRI site (underlined) starting at
nucleotide 1074 (TCAGAATTCGATGACCTCAAAGTTGG)
of the GI24 gene (Gene bank accession no. NM_022153). An
amplified fragment was digested with EcoRI and inserted into
the EcoRI site of the pEAK8-FLAG, and pEAK-HA vectors to
make GI24-F and GI24-HA, respectively, as described previ-
ously.(23) The expression plasmid for GI24 tagged with FLAG
epitope at NH2-terminus was constructed as follows: a GI24
cDNA fragment encoding full-length GI24 lacking the signal
sequence was generated using the PCR forward primer with an
extra EcoRI site (underlined) starting at nucleotide 237
(TCAGAATTCTTCAAGGTCGCCACGC) and reverse primer
with an extra XbaI site (underlined) starting at nucleotide 1080
(TCA- TCTAGAGGGCTAGATGACCTCAAAGTTTGG). The
PCR-amplified fragment was digested with EcoRI and XbaI and
inserted into the pEAK8 vector-containing signal sequence of
the testican-1 gene and the FLAG sequence.
Preparation of recombinant GI24 protein. cDNA fragment
encoding amino acids 56–194 (ectodomain) was generated by
PCR using a flanking forward primer with an extra HindIII site
(underlined) starting at nucleotide 307 (Gene bank accession no.
NM_022153) (GATCAAGCTTCTTGGGCCCTGTGGACAA)
and a flanking reverse primer with an extra EcoRI site (under-
lined) starting at nucleotide 708 (TCAGAATCCTGCAG
CCGTGATGTTT). The amplified DNA fragment was digested
with HindIII and EcoRI and inserted into the HindIII and EcoRI
sites of glutathione S-transferase (GST) plasmid.(13) GI24–GST
fusion proteins were purified using glutathione-Sepharose beads
according to the manufacturer’s instructions (Amersham Bio-
sciences, Upsala, Sweden).
Expression cloning. Expression cloning to identify the candi-
date genes whose products interact with MT1-MMP was carried
out using the modified method of Miyamaori et al.(23) In brief,
plasmid DNA from placenta cDNA library aliquots (400 ng)
was co-transfected with an MT1-MMP plasmid (100 ng) into
HEK293T cells cultured in a 24-well microplate. At 48 h post-
transfection, cells were incubated with MMP-2 sample for 1 h,
and were then subjected to gelatin zymography. A pool of
cDNA, transfection of which promoted MMP2 processing, was
used to transform E. coli. A plasmid DNA from an individual
bacterial colony, expression of which promoted activation of
MMP-2 by MT1-MMP, was selected and the nucleotide
sequence was determined as described previously.(23)
Western blotting. Cell lysates or proteins precipitated from
conditioned medium with 10% Trichloroacetic acid were ana-
lyzed using western blotting with the indicated antibodies. Goat
anti-mouse or anti-rabbit IgG antibodies conjugated with Alexa
Fluor 680 (Molecular Probes Inc., Eugene, OR, USA) were used
as a second antibody. The signal was monitored using a LI-COR
Odyssey IR imaging system (Lincoln, NE, USA). Precision Plus
Protein Standards were used as molecular weight standards
(Bio-Rad, Hercules, CA, USA). HT1080 cells stably expressing
GI24 were established by selecting cells transfected with GI24-
F plasmid (HT1080 ⁄GI24-F) in culture medium containing
0.5 lg ⁄mL puromycin.
Cell surface biotinylation. At 48 h post-transfection, cell-sur-
face biotinylation and immunoprecipitation were performed as
described previously.(24) The immunoprecipitated materials
were separated using 12% sodium dodecyl sulfate-polyacryl-Sakr et al.amide gel electrophoresis, then blotted and detected with IR-
Dye800-conjugated streptavidin.
Immunofluorescence staining. HT1080 ⁄GI24-F cells were
fixed with 4% paraformaldehyde, permeabilized with 0.2% Tri-
ton X-100, stained with anti-FLAG M2 antibody, and examined
on a Zeiss LSM5 EXCITER confocal microscope.
Quantitative real-time PCR assay. Real-time PCR analysis
was performed as described previously.(25) The GI24 mRNA
level was examined using forward primer (GTTGCTAACCAG-
GATGCTGG) starting at nucleotide 4296 and reverse primer
(CAGACATGGCTATCTATCTCG) starting at nucleotide 4543
of the GI24 gene. Hs_GAPDH_1_SG QuantiTect Primer (Qia-
gen, Gaithersburg, MD, USA) was used to monitor the amplifi-
cation of GAPDH gene transcript as a control.
RNA interference. Small interfering RNA (siRNA) targeting
GI24 mRNA was designed and prepared by Nippon EGT (Toy-
ama, Japan). The siRNA target sequences were as follows:
MT1-MMP, 5-AACAGGCAAAGCTGATGCAGA); GI24-1,
TAGGAGATCAATCAGGAATTA; GI24-2, 5¢-ATGAAGC-
GGGATGCTATTAAA. Scrambled control RNA duplex was
used to serve as a negative control for the RNA interference
response. Transfection was carried out using LipofectaminR-
NAiMAX (Invitrogen, Carlsbad, CA, USA) by the reverse trans-
fection method, according to the manufacturer’s instructions.
Collagen gel invasion assay and culture. Type I collagen was
obtained from Nippon Meat Packers (Osaka, Japan). HT1080
cells transfected with the indicated plasmid (2 · 105 cells) were
suspended in 100 lL collagen mixture (3.5 mg ⁄mL), and a
50 lL-drop of collagen gel-containing cells was polymerized on
the bottom of a 24-well microplate and incubated in 0.5 mL
medium for 3 days. For collagen gel culture, 1 · 104 HSC-4
cells transfected with siRNA were embedded in 100 lL collagen
gel, and cultured in 0.5 mL medium for 6 days.
Results
Screening of the cDNA library. Aliquots of plasmid DNA
from the human placenta cDNA library were co-transfected with
MT1-MMP cDNA into HEK293T cells, and the cells were incu-
bated with MMP-2. Then, the cell lysates were analyzed by gel-
atin zymography (Fig. 1). Transfection of one pool of cDNACancer Sci | November 2010 | vol. 101 | no. 11 | 2369
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partially stimulated processing of MMP-2 to the 62-kDa active
form. Four cDNA clones of 12 clones from this cDNA pool
were isolated by a second screening, transfection of which
enhanced MMP-2 processing to the active form. The size of all
four cDNA clones was 1.1 kb. Homology search analysis of its
nucleotide sequence revealed that this cDNA encodes platelet
receptor GI24 precursor (GI24) (GenBank accession no.
NM_022153), which has many synonyms, including SISP1, and
chromosome 10 open-reading frame 54 (C10orf54). Gene GI24
encoded a 34-kDa of 311 amino acids consisting of an extracel-
lular region, a transmembrane segment, and a cytoplasmic tail.
The extracellular region comprised a signal peptide and Ig V-set
domain (Ig-like) as predicted by SMART.(22) Three N-linked
glycosylation sites were identified in the extracellular region,
which may contribute to the glycosylation of GI24 protein.
Overall, the structure of GI24 closely resembles Ig-like cell
adhesion molecules.
GI24 enhances MT1-MMP-mediated MMP-2 activation. GI24
tagged with HA epitope at the COOH-terminus was co-
expressed with MT1-MMP in HEK293T cells, and MMP-2 acti-(A) (B)
Fig. 2. GI24 stimulates membrane type 1–matrix metalloproteinase (MT1
(400 ng) was co-transfected with control or MT1-F plasmid (100 ng) into
culture, cells were either incubated with a MMP-2 sample for gelatin zym
M1 antibody to detect the MT1-MMP active form (a-FLAG M1), anti-FLAG
anti-HA antibody to detect GI24-HA (a-HA). MT1-F plasmid (500 ng) wa
HEK293T cells cultured in a 6-well microplate. The cells were labeled a
materials were blotted with IRDye800-conjugated streptavidin as indicated
with either control plasmid or expression plasmid for MT-MMP (400 ng
serum-free medium, and cells were incubated for a further 24 h. Cultu
analyzed by western blotting using anti-FLAG M2 and MT1-MMP antibo
either control or MT1-MMP plasmid (500 ng) into HEK293T cells cultured
transfection. Immunoprecipitation was performed using anti-FLAG-M2
conjugated streptavidin (top panel). Expression of GI24-F and MT1-MMP w
antibodies as indicated. (D) The recombinant GI24-GST protein (2 lg) w
domain (0.2 lg) for 3 h, separated by 12% SDS-PAGE, and then detected b
blotting using anti-GST antibody (a-GST). Note that 40 kDa GI24-GST p
recombinant MT1-MMP to generate the 26 kDa fragment.
2370vation and expression of MT1-MMP were examined by gelatin
zymography and western analysis, respectively (Fig. 2A).
Co-expression of GI24 with MT1-MMP augmented MMP-2
activation as shown above, and induced accumulation of the
active form of MT1-MMP (52 kDa) on the cell surface. GI24
protein was detected as two bands of approximately 50 and
60 kDa. Co-expression of MT1-MMP with GI24 reduced the
level of the 60 kDa form, and generated major 25-kDa and
minor 35-kDa COOH-terminal fragments; however, the level of
the 50 kDa form was not altered. Next, GI24 tagged with FLAG
epitope at the NH2-terminus was co-expressed with MT1-MMP,
and shedding of the GI24 NH2-terminal extracellular domain
into the culture medium was examined (Fig. 2B). An NH2-
terminal 30 kDa fragment of GI24 was detected in the culture
medium from cells co-expressing GI24 and MT1-MMP. Cell-
surface labeling detected only a 60 kDa but not a 50 kDa
species of GI24, indicating that a 60 kDa species appears on the
cell surface after modification of the 50 kDa immature form,
and only the cell-surface 60 kDa form of GI24 was cleaved
to shed the extracellular domain by MT1-MMP (Fig. 2C).(C) (D)
-MMP) activity. (A) Control plasmid or expression plasmid for GI24-HA
HEK293T cells plated in 24-well plates. Twenty four hours after the
ography (top panel) or subjected to western blotting with anti-FLAG
M2 antibody to detect active and latent MT1-MMP (a-FLAG M2), and
s co-transfected with either control or GI24-HA plasmid (500 ng) into
nd immunoprecipitated by anti-FLAG-M2 beads, and the precipitated
. NS, non-specific band. (B) F-GI24 plasmid (200 ng) was co-transfected
). At 24 h after transfection, the culture medium was replaced with
re supernatants (panel CM) and cell lysates (panels WCL) were then
dy as indicated. (C) GI24-F plasmid (500 ng) was co-transfected with
in a 6-well microplate, and cells were labeled with biotin at 48 h after
beads, and the precipitated materials were blotted with IRDye800-
as confirmed with cell lysates using anti-FLAG M2 and anti-MT1-MMP
as incubated with or without the recombinant MT1-MMP catalytic
y either Coomassie Brilliant Blue staining (protein staining) or western
rotein and co-purified 30 kDa degradation product were cleaved by
doi: 10.1111/j.1349-7006.2010.01675.x
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Cleavage of GI24 by MT1-MMP was examined by an in vitro
experiment using recombinant MT1-MMP and GI24 proteins
(Fig. 2D). MT1-MMP cleaved GI24 at a site close to the trans-
membrane domain.
GI24 enhances invasion of HT1080 cells into collagen




Fig. 3. GI24 enhances invasiveness of HT1080 cells. (A) HT1080 cells tran
treated with 1 lM BB94 (lanes BB94) or siRNA for membrane type 1–matr
to western blotting using anti-FLAG M2 or anti-MT1-MMP antibody. (B
transfected with si-RNA for MT1-MMP, and then immunostained using a
HT1080 cells transfected with control plasmid and two independent clo
gelatin zymography or subjected to western blotting using anti-MT1-M
HT1080 cells ()), control HT1080 cells and two independent clones of HT
were cultured in 0.5 mL culture medium. Photography was taken 2 and
collagen gel. Magnification, ·40. The area framed in white is expanded in
collagen gel and degraded the collagen gel more than the control cells.
Sakr et al.stimulated MT1-MMP-mediated MMP-2 activation. To exam-
ine the physiological relevance of interaction between GI24
and MT1-MMP, the GI24-F gene was stably transfected into
HT1080 fibrosarcoma cells (HT1080 ⁄GI24-F), which express
endogenous MT1-MMP. GI24 COOH-terminal fragments of 35
and 25 kDa were detected in HT1080 ⁄GI24-F cells (Fig. 3A).sfected with control or GI24-F plasmid were mock-treated (lane -) or
ix metalloproteinase (MT1-MMP) (lanes si-MT1) for 24 h, and subjected
) Control HT1080 cells or HT1080 ⁄GI24-F cells were mock-treated or
nti-FLAG M2 antibody. Scale bar, 10 lm. (C) Parental HT1080 cells ()),
nes of HT1080 ⁄GI24-F were either incubated with MMP-2 sample for
MP, anti-FLAG M2 or anti-tubulin antibody as indicated. (D) Parental
1080 ⁄GI24-F (1 · 105 cells) embedded in a 50 lL drop of collagen gel
3 days after the culture. The dotted line represents the border of the
the bottom panels. Note that HT1080 ⁄GI24-F cells invaded out of the
Cancer Sci | November 2010 | vol. 101 | no. 11 | 2371
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Treatment of HT1080 ⁄GI24-F cells with an MMP inhibitor
BB94 attenuated production of 25 and 35 kDa fragment and
recovered 60 kDa species. Tranasfection of siRNA for MT1-
MMP reduced the MT1-MMP level by more than 90%, and 25
and 35 kDa species of GI24 were lost and 60 kDa species
recovered in HT1080 ⁄GI24-F cells. The MT1-MMP level was
significantly higher in HT1080 ⁄GI24-F cells than in the control
cells. GI24-F of the 60 kDa form was immunolocalized on the
cell membrane, and the cleavage products of 25 kDa and
35 kDa COOH-terminal fragments were also detected predomi-
nantly at the cell membrane (Fig. 3B).(A)
(C)
Fig. 4. GI24 stimulates invasive growth of HSC-4 cells. (A) GI24 and mem
compared using quantitative real-time PCR analysis. For gelatin zymogr
washed with PBS before being dissolved in the sample buffer. (B) HSC-4 c
GI24 or MT1-MMP, and analyzed by western blotting using anti-GI24
performed as described above. (C) HSC-4 cells were mock-treated or trans
gel for 6 days. Original magnification, ·100.
2372To confirm the stimulatory effect of GI24 expression on
MT1-MMP activity, two independent clones of HT1080 ⁄GI24-F
cells were examined for MMP-2 activation (Fig. 3C). Both
clones of HT1080 ⁄GI24-F cells activated MMP-2 more
effectively, and express a significantly higher level of 52 kDa
active MT1-MMP and 40 kDa its auto-degradation product
than parental HT1080 cells or cells transfected with control
plasmid.
To examine the possible contribution of GI24 to invasive
growth, HT1080 ⁄GI24-F cells were cultured in collagen matrix,
and cells which invade out from the gel were monitored(B)
brane type 1–matrix metalloproteinase (MT1-MMP) mRNA levels were
aphy, cells were incubated with a MMP-2 sample for 1 h, and then
ells were mock-treated or transfected with control siRNA or siRNA for
, anti-MT1-MMP or anti-tubulin antibody. Gelatin zymography was
fected with control siRNA or siRNA for GI24, and cultured in collagen
doi: 10.1111/j.1349-7006.2010.01675.x
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(Fig. 3D). HT1080 ⁄GI24-F cells invaded out more frequently
than parental cells or cells transfected with control plasmid. Col-
lagen gel degradation was more intense in the culture of
HT1080 ⁄GI24 cells than that of the parental or control cells.
Roles of GI24 in invasive growth of squamous carcinoma
cells. The mRNA levels of GI24 and MT1-MMP in tumor cell
lines were compared using real-time PCR analysis (Fig. 4A).
Squamous carcinoma cell lines HSC-3 and HSC-4 and hepato-
carcinoma cell lines PLC5 and Huh7 express GI24 mRNA at a
relatively high level, and HT1080, HSC3 and HSC-4 cells
express relatively high levels of MT1-MMP. Consistent with the
MT1-MMP mRNA level, MMP-2 activation was observed in
these cells. Thus, HSC-4 cells were used for further study to
examine the interaction between GI24 and MT1-MMP. GI24
expression was knocked down by transfection of siRNA for
GI24, and MT1-MMP expression and MMP-2 activation by
these cells were analyzed (Fig. 4B). Transfection of siRNA for
GI24 reduced its expression level, which significantly attenuated
the MT1-MMP level and MMP-2 activation. Knockdown
of MT1-MMP significantly increased the GI24 protein level.
HSC-4 cells transfected with GI24 siRNA were cultured in 3-D
collagen gel (Fig. 4C). HSC-4 cells or cells transfected with
control siRNA formed a branched rod-like structure, but GI24
siRNA-transfected cells formed a more spherical shape in the
collagen gel.
Discussion
We have identified KiSS-1 ⁄metastin, syndican-1, testican ⁄N-
Tes, lumican, amyloid-b precursor protein (APP), apolipopro-
tein E and GDF-15 using the expression cloning strategy as
molecules which serve as regulators or substrates for
MT1-MMP.(13,24,26–30) Among these molecules, APP and
GDF-15 not only served as substrates for MT1-MMP, but also
stimulated MT1-MMP-mediated MMP-2 activation. In contrast,
the lumican gene was isolated, the product of which suppressed
MT1-MMP-mediated MMP-2 activation but served as a
substrate like other positive regulators. In the present study,
we found that GI24 also serves not only as a substrate but also
a positive regulator of MT1-MMP. In HEK293T cells,Sakr et al.co-expression of GI24 augmented the level of active MT1-
MMP, which consequently enhanced MMP-2 activation. Stable
transfection of the GI24-F gene into HT1080 cells augmented
the MT1-MMP level and MMP-2 activation, and thus
HT1080 ⁄GI24-F cells showed more intensive degradation of
collagen gel and invasion into it. GI24 expression was high in
some squamous carcinoma and hepatocellular carcinoma cells.
Down-regulation of GI24 expression by transfection of siRNA
for GI24 attenuated MT1-MMP activity and invasive growth in
the collagen matrix. These results suggest that GI24 contributes
to the invasive growth of carcinoma cells by up-regulating cell-
surface MT1-MMP. Cell-surface MT1-MMP is regulated
through a variety of processes such as a dimer formation, inter-
nalization, interaction with cell-surface molecules, tetraspanin-
regulated cell surface localization and autodegradation.(19,20)
Interaction of GI24 with MT1-MMP positively regulates cell
surface localization of MT1-MMP, although the detailed mecha-
nism still remains to be solved. Deletion of transmembrane and
cytoplasmic domains of GI24 abolished the positive regulatory
effect on MMP-2 activation, indicating that cell-surface locali-
zation of GI24 is essential for it (data not shown). Another syno-
nym of GI24 is SISP-1. MT1-MMP expression is induced in
diverse physiological events such as tumor progression and tis-
sue injury, which may shed the extracellular domain of GI24.
The structure of GI24 closely resembles Ig-like cell adhesion
molecules (PECAM-1 HepaCAM, ICAM-1 and ICAM-2).(31–33)
Actually, GI24 was shown to enhance cellular adhesion to fibro-
nectin (data not shown). GI24 is cleaved at the juxtamembrane
site to shed the extracellular domain, which consequently abro-
gates enhanced adhesion to fibronectin. Thus far, the physiologi-
cal significance of GI24-mediated cell adhesion still remains to
be solved, but it might be possible that shed GI24 negatively
regulates cellular adhesion to fibronectin.
In conclusion, we demonstrated for the first time that GI24
not only serves as a substrate for MT1-MMP but also stimulates
MT1-MMP activity, and the stimulatory function of GI24 may
contribute, at least in part, to tumor invasion and metastasis.
Thus, the association between MT1-MMP and GI24 could be a
target to regulate MT1-MMP activity and subsequent tumor
growth in extracellular matrices.References
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